期刊文献+

Galectin-3及CyclinD1在良恶性甲状腺肿块中的鉴别价值 被引量:8

The differential diagnosis value of Galectin-3 and Cyclin D1 in benign and malignant thyroid mass
原文传递
导出
摘要 目的探讨Galectin-3和CyclinD1在良、恶性甲状腺肿块中的表达及鉴别价值。方法用免疫组化(SP)法检测31例结节性甲状腺肿(A组)、65例甲状腺乳头癌(B组)及10例正常甲状腺组织(c组)石蜡标本中Galectin-3蛋白和CyclinD1蛋白的表达,并结合临床资料分析。结果B组中Galectin.3的阳性率为83.03%(54/65),显著高于A组的19.35%(6/31)和C组(0%),前2组比较差异有统计学意义(X^2=36.360,P〈0.05);B组中CyclinD1的阳性率为72.30%(47/65),显著高于A组12.90%(4/31)和C组(0%),前2组比较差异有统计学意义(X^2=29.740,P〈0.05);联合检测Galectin-3和CyclinD1在良、恶性甲状腺肿瘤中的表达,发现阳性表达差异有统计学意义(P〈0.01),且Galectin-3和CyclinD1在B组中的表达也存在正相关(R=0.509,P〈0.05)。CyclinD1蛋白在有无淋巴结转移的甲状腺乳头癌中的阳性率分别为90%(18/20)和64.44%(29/45),差异有统计学意义(P〈0.05)。结论Galectin-3和CyclinD1在甲状腺乳头癌组织中的阳性表达存在正相关性,较结节性甲状腺肿和正常组织有强阳性表达,联合检测甲状腺组织中β-catenin及Galcetin-3的表达有助于甲状腺癌的诊断。 Objectives To investigate the expression and differential diagnosis value of Galectin-3 and Cyclin D1 in benign and malignant thyroid mass. Methods The expression of Galectin-3 and Cyclin D1 protein in 31 cases of nodular goiter( group A), 65 cases of papillary thyroid carcinoma( PTC, group B)and 10 cases of normal thyroid tissues( group C, the control group)was detected by SP immunohistochemical method. The clinical data were analyzed. Results The expression level of Galectin-3 in group B was 83.03% (54/65), significantly higher than that in group A( 19.35%, 6/31 )and group C(0% ). The difference of group A and group B in terms of the expression level of Galectin-3 protein had statistical significance(x^2 = 36. 360, P 〈 0. 05 ). The expression level of Cyclin DI protein in group B was 72. 30% (47/65), significantly higher than that in group A( 12. 90%, 4/31 )and group C(0% ). The difference of group A and group B in terms of the expression level of Cyclin D1 protein had statistical significance (X2 = 29. 740, P 〈 0. 05). The combination detection of the positive expression of Galectin-3 and Cyclin D1 in benign and malignant thyroid mass showed that the difference between group A and group B had statistical significance( P 〈0. 01 ). The expression of Galectin-3 and Cyclin D1 was positively corre- lated in group B ( R = 0. 509, P 〈 0.05 ). The positive expression rate of Cyclin D1 protein was 90% (18/20) and 64. 44% (29/45)respectively in PTC patients with lymph node metastasis and without lymph node metastasis. The difference had statistical significance (P 〈 0. 05 ). Conclusions The expression of Galectin-3 and Cyclin D1 is positively correlated in PTC and the expression of the 2 proteins in PTC is higher than that in nodular goiter and normal thyroid tissues, indicating that the 2 proteins can be used as valuable markers for patients with thyroid carcinoma. Combined detection of Cyclin D1 and Galectin-3 protein in thyroid tissues is useful for the diagnosis of thyroid cancer.
机构地区 [ 海南大学农学院
出处 《中华内分泌外科杂志》 CAS 2013年第1期34-37,41,共5页 Chinese Journal of Endocrine Surgery
基金 海南省自然科学基金(309084)
关键词 GALECTIN-3 CYCLIN D1 免疫组化 甲状腺癌 Galectin-3 Cyclin D1 Immunohistochemistry Thyroid cancer
  • 相关文献

参考文献12

  • 1Jemal A,Siegel R,Ward E. Cancer statistics,2009[J].CA:A Cancer Journal for Clinicians,2009,(04):225.
  • 2Hegedüs L,Clinical practice. The thyroid nodule[J].New England Journal of Medicine,2004,(17):1764-1771.
  • 3施秉银.甲状腺结节和肿瘤的诊断、治疗与展望[J].中华内分泌代谢杂志,2003,19(2):83-85. 被引量:67
  • 4Lin CI,Whang EE,Abramson MA. Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells[J].Biochemical and Biophysical Research Communications,2009,(02):626-631.doi:10.1016/j.bbrc.2008.12.153.
  • 5Chiu CG,Strugnell SS,Griffith OL. Diagnostic utility of galectin-3 in thyroid cancer[J].American Journal of Pathology,2010,(05):2068-2081.
  • 6Dirks PB,Rutka JT. Current concepts in neuro-oncology:the cell cycle-areview[J].Neurosurgery,1997,(05):1000-1013.
  • 7Matarrese P,Fusco O,Tinari N. Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties[J].International Journal of Cancer,2000,(04):545-554.
  • 8Takenaka Y,Fukumori T,Raz A. Galectin-3 and metastasis[J].Glycoconjugate Journal,2004.543-549.
  • 9Saleh HA,Jin B,Barnwell J. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules[J].Diagnostic Pathology,2010.9.
  • 10Lee SH,Lee JK,Jin SM. Expression of cell-cycle regulators (cyclin D1,cyclin E,p27kipl,p57kip2)in papillary thyroid carcinoma[J].Otolaryngology Head and Neck Surgery,2010,(03):332-337.

二级参考文献2

  • 1胡锡琪,叶诸榕,徐宜华,黄超.甲状腺隐匿癌的发生与发展的探讨——13例尸检的形态观察和分析[J]肿瘤,1982(01).
  • 2龚益.甲状腺疾病的诊断治疗进展[J].国外医学(内分泌学分册),2001,21(4):174-176. 被引量:17

共引文献66

同被引文献82

  • 1李文波,朱庆莉,张波,姜玉新,杨堤.超声引导下细针吸取细胞学检查对甲状腺结节的诊断价值[J].中国医学科学院学报,2010,32(1):76-80. 被引量:45
  • 2黄晓烽,周建波,杜桄,潘小红,徐瑞华.胃癌患者血清Endostatin和VEGF水平变化及意义[J].中华消化内镜杂志,2006,23(3):200-203. 被引量:5
  • 3Wong AS ,Gumbiner BM. Adhesion-independent mechanism for sup- pression of tumor cell invasion by E-cadherin[J]. J Cell Biol,2003, 161 (16) : 1191-1203,.
  • 4武正炎.甲状腺疾病//吴在德,吴肇汉,郑树,等.外科学[M].7版.北京:人民卫生出版社,2009:298.
  • 5王德田.病理细胞学穿刺技术//王德田,董建强.实用现代病理学技术[M].北京:中国协和医科大学出版社,2013:329.
  • 6Cooper DS. Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2009, 19 : 1167-1214.
  • 7丁伟.免疫组织化学染色技术//丁伟,王德田,董建强,等.简明病理学技术[M].1版.杭州:浙江科学技术出版社,2014:133-239.
  • 8Zhu X, Sun T, Lu H, et al. Diagnostic significance of CK19, RET, Galectin-3 and HBME-1 expression for papillary thyroid carcinoma [ J ]. J Clin Patho1,2010,63 (9) :786-789.
  • 9Schmitt AC, Cohen C, Siddiqui MT. Paired box gene 8, HBME-1 and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility [ J ]. Cancer CvtoDathol. 2010.118 ( 4 ) : 196 -202.
  • 10Song Q,Wang D, Lou Y,et al. Diagnostic significance of CKI9, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China [ J ]. Diagn Pathol, 2011,21 (6) :126-132.

引证文献8

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部